Defining the risks of mesenchymal stromal cell therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Defining the risks of mesenchymal stromal cell therapy

Published:2010-09 Issue:5 Volume:12 Page:576-578
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Prockop Darwin J.,Brenner Malcolm,Fibbe Willem E.,Horwitz Edwin,Le Blanc Katarina,Phinney Donald G.,Simmons Paul J.,Sensebe Luc,Keating Armand

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics(clinical),Oncology,Immunology,Immunology and Allergy

Reference16 articles.

1. Induction of pluripotent stem cells from mouse fibroblasts by four transcription factors;Yamanaka;Cell Prolif,2008

2. Human iPS cell derivation/reprogramming;Park;Curr Protoc Stem Cell Biol,2009

3. Multistage carcinogenesis in cell culture;Rubin;Dev Biol (Basel),2001

4. Normal human mammary epithelial cells spontaneously escape senescence and acquire genomic changes;Romanov;Nature,2001

5. Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms;Bernardo;Cancer Res,2007

Cited by 281 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inter- and Intra-donor variability in bone marrow–derived mesenchymal stromal cells: implications for clinical applications;Cytotherapy;2024-09

2. Advancements in diabetic foot ulcer research: Focus on mesenchymal stem cells and their exosomes;Heliyon;2024-09

3. Elastic Nanofibrous Dressings with Mesenchymal Stem Cell-Recruiting and Protecting Characteristics for Promoting Diabetic Wound Healing;ACS Applied Materials & Interfaces;2024-08-05

4. Mesenchymal stem cells for cartilage regeneration: Insights into molecular mechanism and therapeutic strategies;Tissue and Cell;2024-06

5. An exploratory open-label multicentre phase I/II trial evaluating the safety and efficacy of postnatal or prenatal and postnatal administration of allogeneic expanded fetal mesenchymal stem cells for the treatment of severe osteogenesis imperfecta in infants and fetuses: the BOOSTB4 trial protocol;BMJ Open;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3